InVivoMAb anti-rat FcRn heavy chain heterodimers
About InVivoMAb anti-rat FcRn heavy chain heterodimers
The 2G3 antibody was raised against soluble rat neonatal Fc receptor (FcRn) in an adjuvant. FcRn is a heterodimer composed of a membrane bound heavy chain attached non-covalently to β2-microgloublin. It is structurally similar to MHC class I molecules. The 2G3 antibody is used in studies of the MHC class I heavy chain FcRn heterodimers and their interaction with IgG.
InVivoMAb anti-rat FcRn heavy chain heterodimers Specifications
|Recommended Isotype Control(s)||InVivoMAb mouse IgG1 isotype control, unknown specificity(BE0083)|
|Recommended InVivoPure Dilution Buffer||InVivoPure pH 7.0 Dilution Buffer(IP0070)|
Purified soluble FcRn
0.2 μM filtered
Purified from tissue culture supernatant in an animal free facility
The antibody solution should be stored undiluted at 4°C, and protected from prolonged exposure to light. Do not freeze.
InVivoMAb anti-rat FcRn heavy chain heterodimers (Clone: 2G3)Raghavan, M., et al. (1994). "Investigation of the interaction between the class I MHC-related Fc receptor and its immunoglobulin G ligand." Immunity 1(4): 303-315. PubMed
The neonatal Fc receptor (FcRn) is structurally similar to class I major histocompatibility molecules. FcRn transports maternal immunoglobulin G (IgG) from ingested milk into the blood. IgG is bound at the pH of milk (pH 6.0-6.5) in the gut and released at the pH of blood (pH 7.5). We find that alteration of a histidine pair within the alpha 3 domain of FcRn and of a nearby loop (the FcRn counterpart of the class I CD8-binding loop) affects the affinity for IgG. Inhibition studies suggest the involvement of the FcRn B2-microglobulin domain in IgG binding. Fragment B of protein A inhibits FcRn binding to IgG, localizing the binding site on Fc for FcRn to the CH2-CH3 domain interface. Three histidines present at the CH2-CH3 domain interface of Fc could be partially responsible for the pH-dependent interaction between FcRn and IgG.